- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00752024
Stereotactic Aspiration and Thrombolysis of Intracerebral Hemorrhage: a Prospective Controlled Study (SATIH)
Stereotactic Aspiration and Thrombolysis of Intracerebral Hemorrhage: a Prospective Controlled Study(SATIH)
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The stereotactic computed tomographic-guided aspiration and drainage is one of the best choices in the treatment of a large-scale deep supratentorial intracerebral hematoma. It uses hardware access technology, in a relatively short time to enter the hematoma center, with suction liquefaction technology. It has the advantage of a higher clearance rate of the hematoma, simple convenience, small trauma and low-cost. We carry on the suitable improvement in this technology's foundation in view of its deficiency, the introduction of the concept of the individual, will further reduce the rate of bleeding and mortality, improve survival, such as long-term quality of life.
We will adopt scales such as the rate of rebleeding, mortality, complication,NIHSS, MRS, BI, GOS scale to analysis and evaluating efficacy and safety of this technology and conservative treatment in the treatment of HICH.
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: wei wang, doctor
- Telefonnummer: 86-027-8366-3648
- E-post: daodetongji@163.com
Studera Kontakt Backup
- Namn: zhouping tang, doctor
- Telefonnummer: 86--013971616328
- E-post: ddjtzp@163.com
Studieorter
-
-
Hubei
-
Wuhan, Hubei, Kina, 430030
- Department of Neurology of Tongji Hospital, Huazhong University of Science and Technology
-
Kontakt:
- zhouping tang, doctor
- Telefonnummer: 86-013971616328
- E-post: ddjtzp@163.com
-
Kontakt:
- wei wang, doctor
- Telefonnummer: 86-027-8366-3648
- E-post: daodetongji@163.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- CT diagnosis of spontaneous supratentorial intracerebral hemorrhage, the amount of bleeding more than 50 ml, and had neurological signs
- All income groups the incidence of medical records to be random, the time should be < 69 hours to ensure that within 72 hours of the onset of the operation
- To be random, former GCS score > = 5 points
- Systolic blood pressure <= 200 mmHg, mean arterial pressure <= 150 mmHg (if higher than this value, but as corresponding to this standard can be dealt with the group, and only reached the standard before they can ask for random)
- Fasting plasma glucose <= 11.1 mmol / L (if higher than this value, but as corresponding to this standard can be dealt with the group, and only reached the standard before they can ask for random)
- Patients aged 18 to 80-year-old.
- Based on China's relevant laws, the patient himself or family members (only in patients with the loss of his ability to judge the acts of circumstances) agreed to participate in this study, a good compliance, to fully comply with random, in accordance with the decision by the treatment, patients himself Or family members must sign informed consent moreover.
- Patients themselves or their families (only in patients with the loss of his ability to judge the acts of circumstances) have willingness and ability to follow the research program, data collection and preservation of history and follow-up process of informed consent.
Exclusion Criteria:
- Patients clotting mechanisms are obstacles or having the experience of the use of anticoagulant drug (PT> 15s, APTT> 40s, INR> 1.4, platelet count <100 × 10 9 / L).
- Cerebral hernia formed more than two hours
- The merger of other serious system failure (heart, liver and kidney, etc.) or a variety of end-stage disease with cerebral hematoma (such as renal failure late cerebral hemorrhage, blood disease with cerebral hemorrhage)
- Prior to the onset of a variety of reasons for the defect or neurological movement disorder
- A clear cause of cerebral hemorrhage such as intracranial aneurysm, or dynamic
- such as a venous malformation
- Intracranial or serious systemic infection
- Marked cognitive impairment or mental abnormality
- Other such as pregnancy, cancer
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: 1
To position haematoma's location, drills several millimeter holes in the localization point of puncture, then insert the drainage tube to inhale haematoma, gives the filament resolver interrupted for liquefication drainage afterward.
|
YL-1 type of intracranial hematoma puncture needle(Pat. NO.is ZL:93244252•8) was originated by Beijing WanTeFu Medical Apparatus Co.Ltd in 1997. With integration of needle and bur drill it is designed as hard tunnel.By the technique of skull self-holding, the puncture needle can being fixed in the target of haematoma for several days.This technique is convenient, simple and safe. To position haematoma's location, drills 3 millimeter holes in the localization point of puncture, then insert the drainage tube to inhale haematoma, gives the filament resolver interrupted for liquefication drainage afterward.
Andra namn:
|
Aktiv komparator: 2
In the treatment, under the convention we use the dehydrator for patients, the ultra early patient may use anti-filament medicinal preparation 6- amino-caproic acid 6-12g/d, intravenous drip, the period of revolution does not surpass for 24 hours, then just right for the illness treatment.
|
In the treatment, under the convention we use the dehydrator for patients, the ultra early patient may use anti-filament medicinal preparation 6- amino-caproic acid 6-12g/d, intravenous drip, the period of revolution does not surpass for 24 hours, then just right for the illness treatment.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Frekvensen av återblödning och dödlighet, Glasgow Outcome Scale för prognos
Tidsram: varaktighet på 14 dagar efter operation (återblödning), varaktighet på sjukhusvistelse (mortalitet), 180 dagar efter debut (dödlighet och GOS)
|
varaktighet på 14 dagar efter operation (återblödning), varaktighet på sjukhusvistelse (mortalitet), 180 dagar efter debut (dödlighet och GOS)
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
Nation of Health Stroke Scale Score, modifierad Rankin Scale, Barthel Index komplikationer
Tidsram: intagningsögonblicket och efter operationen (NIHSS), 14 dagar efter intagningen (NIHSS, MRS), sjukhusvistelsens längd (komplikationer), 180 dagar efter debut (BI, MRS)
|
intagningsögonblicket och efter operationen (NIHSS), 14 dagar efter intagningen (NIHSS, MRS), sjukhusvistelsens längd (komplikationer), 180 dagar efter debut (BI, MRS)
|
Samarbetspartners och utredare
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2006AA301B50-1
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Hypertensiv intracerebral blödning
-
Tongji HospitalOkänd
-
Huazhong University of Science and TechnologyOkändHypertensiv intracerebral blödningKina
-
Shanghai Changzheng HospitalXiangya Hospital of Central South University; LanZhou University; Peking... och andra samarbetspartnersHar inte rekryterat ännuHypertensiv intracerebral blödning
-
Shanghai Changzheng HospitalThe First Affiliated Hospital of Nanchang University; Peking Union Medical... och andra samarbetspartnersHar inte rekryterat ännu
-
First Affiliated Hospital, Sun Yat-Sen UniversityJiangsu Simcere Pharmaceutical Co., Ltd.Har inte rekryterat ännuIntracerebral blödning
-
University of RijekaAvslutadHjärnskador | Intraventrikulär blödning | Hypertensiv intracerebral blödning
-
The First People's Hospital of JingzhouAvslutadHematomabsorption och neurologisk funktionsåterställning
-
Wake Forest University Health SciencesAktiv, inte rekryterandeStroke hemorragisk | Intracerebral blödning | Cerebralt ödem | Intracerebral blödning, hypertoni | Intracerebral blödning IntraparenkymalFörenta staterna
-
University Hospital, GrenobleOkändIntrakraniell blödning, hypertensivFrankrike
-
Chinese PLA General HospitalThe First Affiliated Hospital of Nanchang University; First Affiliated... och andra samarbetspartnersAvslutadIntrakraniell blödning, hypertensivKina
Kliniska prövningar på YL-1 type of intracranial hematoma puncture needle
-
Tongji HospitalOkänd